• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

The Neurologic Impact of COVID-19: Early Signs, Past Experience

Slideshow

As neurologic findings among patients with COVID-19 emerge, comparison to sequelae seen with other coronaviruses is instructive.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
The Expanding Role of Family Medicine in Alzheimer Disease and Other Dementias / image credit ©Billion Photos/stock.adobe.com

The Expanding Role of Family Medicine in Alzheimer Disease and Other Dementias

Grace Halsey
October 7th 2025
Article

As dementia care grows more complex and more promising, the role for front-line clinicians is becoming more nuanced and more essential.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 7th 2025
Podcast

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Linus Health Will Highlight Digital Innovations in Early Detection of Cognitive Decline at FMX 2025 / image courtesy of Linus Health

Linus Health Will Highlight Digital Innovations in Early Detection of Cognitive Decline at FMX 2025

Grace Halsey
October 2nd 2025
Article

Linus Health will demonstrate advances in remote assessment platforms and digital biomarkers of cognitive health that can bring precision medicine to primary care.

Make It Routine: Screening for Cognitive Decline in Primary Care

Make It Routine: Screening for Cognitive Decline in Primary Care

Anna Chodos, MD, MPH;Sydney Jennings
July 24th 2025
Podcast

Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.

Cannabis Extract Provides LBP Relief Over 12 Months in Phase 3 Clinical Trial

Cannabis Extract Provides LBP Relief Superior to Opioids Over 12 Months in Phase 3 Clinical Trial

Grace Halsey
October 1st 2025
Article
Donanemab (Kisunla) Authorized in Europe for Early Symptomatic Alzheimer Disease / image credit ©Sergii Figurnyi/stock.adobe.com

Donanemab (Kisunla) Authorized in Europe for Early Symptomatic Alzheimer Disease

Grace Halsey
September 29th 2025
Article

The European Commission granted marketing authorization for the Lilly mAb based on data from the phase 3 TRAILBLAZER-ALZ 2 and 6 clinical trials.

© 2025 MJH Life Sciences

All rights reserved.